228 related articles for article (PubMed ID: 26627686)
1. Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.
Kuzdas-Wood D; Fellner L; Premstaller M; Borm C; Bloem B; Kirik D; Wenning GK; Stefanova N
BMC Neurosci; 2015 Dec; 16():86. PubMed ID: 26627686
[TBL] [Abstract][Full Text] [Related]
2. Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?
Stefanova N; Hainzer M; Stemberger S; Couillard-Després S; Aigner L; Poewe W; Wenning GK
Exp Neurol; 2009 Sep; 219(1):368-71. PubMed ID: 19460374
[TBL] [Abstract][Full Text] [Related]
3. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
[TBL] [Abstract][Full Text] [Related]
4. Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure.
Stemberger S; Poewe W; Wenning GK; Stefanova N
Exp Neurol; 2010 Aug; 224(2):459-64. PubMed ID: 20493840
[TBL] [Abstract][Full Text] [Related]
5. Progressive striatonigral degeneration in a transgenic mouse model of multiple system atrophy: translational implications for interventional therapies.
Refolo V; Bez F; Polissidis A; Kuzdas-Wood D; Sturm E; Kamaratou M; Poewe W; Stefanis L; Angela Cenci M; Romero-Ramos M; Wenning GK; Stefanova N
Acta Neuropathol Commun; 2018 Jan; 6(1):2. PubMed ID: 29298733
[TBL] [Abstract][Full Text] [Related]
6. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
[TBL] [Abstract][Full Text] [Related]
7. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
[TBL] [Abstract][Full Text] [Related]
8. Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: experimental evidence.
Kuzdas D; Stemberger S; Gaburro S; Stefanova N; Singewald N; Wenning GK
Exp Neurol; 2013 Sep; 247():531-6. PubMed ID: 23399889
[TBL] [Abstract][Full Text] [Related]
9. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
[TBL] [Abstract][Full Text] [Related]
10. ATH434 Reduces α-Synuclein-Related Neurodegeneration in a Murine Model of Multiple System Atrophy.
Heras-Garvin A; Refolo V; Schmidt C; Malfertheiner K; Wenning GK; Bradbury M; Stamler D; Stefanova N
Mov Disord; 2021 Nov; 36(11):2605-2614. PubMed ID: 34236731
[TBL] [Abstract][Full Text] [Related]
11. Increased neuronal α-synuclein pathology associates with its accumulation in oligodendrocytes in mice modeling α-synucleinopathies.
Kisos H; Pukaß K; Ben-Hur T; Richter-Landsberg C; Sharon R
PLoS One; 2012; 7(10):e46817. PubMed ID: 23077527
[TBL] [Abstract][Full Text] [Related]
12. Neuropathology of multiple system atrophy: new thoughts about pathogenesis.
Jellinger KA
Mov Disord; 2014 Dec; 29(14):1720-41. PubMed ID: 25297524
[TBL] [Abstract][Full Text] [Related]
13. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
[TBL] [Abstract][Full Text] [Related]
14. α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.
May VE; Ettle B; Poehler AM; Nuber S; Ubhi K; Rockenstein E; Winner B; Wegner M; Masliah E; Winkler J
Neurobiol Aging; 2014 Oct; 35(10):2357-68. PubMed ID: 24698767
[TBL] [Abstract][Full Text] [Related]
15. Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease.
Marmion DJ; Rutkowski AA; Chatterjee D; Hiller BM; Werner MH; Bezard E; Kirik D; McCown T; Gray SJ; Kordower JH
Neurobiol Dis; 2021 Jan; 148():105184. PubMed ID: 33221532
[TBL] [Abstract][Full Text] [Related]
16. Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
Stefanova N; Kaufmann WA; Humpel C; Poewe W; Wenning GK
Acta Neuropathol; 2012 Jul; 124(1):51-65. PubMed ID: 22491959
[TBL] [Abstract][Full Text] [Related]
17. Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy1.
Jellinger KA
J Alzheimers Dis; 2018; 62(3):1141-1179. PubMed ID: 28984582
[TBL] [Abstract][Full Text] [Related]
18. Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy.
Rockenstein E; Ubhi K; Inglis C; Mante M; Patrick C; Adame A; Masliah E
Neuroreport; 2012 Mar; 23(4):259-64. PubMed ID: 22314685
[TBL] [Abstract][Full Text] [Related]
19. Age-related motor dysfunction and neuropathology in a transgenic mouse model of multiple system atrophy.
Fernagut PO; Meissner WG; Biran M; Fantin M; Bassil F; Franconi JM; Tison F
Synapse; 2014 Mar; 68(3):98-106. PubMed ID: 24243499
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy.
Stefanova N; Reindl M; Neumann M; Haass C; Poewe W; Kahle PJ; Wenning GK
Am J Pathol; 2005 Mar; 166(3):869-76. PubMed ID: 15743798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
